Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income (loss)	$ 7,253	$ 11,291
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Investment related (gains) losses on sale of investments and other assets	1,741	(1,537)
Net deferred policy acquisition cost	(14,488)	(16,500)
Amortization of cost of insurance acquired	305	477
Depreciation	535	443
Amortization of premiums and discounts on investments	3,459	3,738
Stock-based compensation	1,727	1,052
Deferred federal income tax expense (benefit)	1,215	(1,350)
Change in:
Accrued investment income	261	278
Reinsurance recoverable	(3,444)	(3,287)
Due premiums	1,784	1,174
Future policy benefit reserves	(13,118)	1,842
Other policyholders' liabilities	24,494	19,002
Federal income tax receivable	(384)	1,041
Commissions payable and other liabilities	(1,093)	6,397
Other, net	(1,356)	(2,969)
Net cash provided by operating activities	8,891	21,092
Cash flows from investing activities:
Purchases of fixed maturity securities, available-for-sale	(101,344)	(49,345)
Sales of fixed maturity securities, available-for-sale	60,143	4,659
Maturities and calls of fixed maturity securities, available-for-sale	30,354	37,907
Purchases of equity securities	(120)	0
Sales of equity securities	4,482	0
Principal payments on mortgage loans	6	7
Change in policy loans	2,499	2,896
Sales of other long-term investments	1,603	2,226
Purchases of other long-term investments	(8,443)	(11,123)
Purchase of property and equipment	(343)	(561)
Net cash used in investing activities	(11,163)	(13,334)
Cash flows from financing activities:
Annuity deposits	6,939	5,181
Annuity withdrawals	(10,535)	(7,183)
Other share repurchases	(280)	(371)
Net cash used in financing activities	(3,876)	(2,373)
Net increase (decrease) in cash and cash equivalents	(6,148)	5,385
Cash and cash equivalents at beginning of year	29,271	26,997
Cash and cash equivalents at end of period	$ 23,123	$ 32,382

Net amount of other increase (decrease) to capitalized and amortized expense of deferred policy acquisition costs (DAC)

No definition available.

Name:	cia_NetDeferredPolicyAcquisitionCostExpense
Namespace Prefix:	cia_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.